Evidence map›Paper›PMID 40248583›Full record

ArticleMedecine tropicale et sante internationale2025

[Time of entry into care of people living with HIV in two outpatient treatment centers of Libreville, Gabon, between 2012 and 2020].

Michèle Marion Ntsame Owono, Magalie Essomeyo Ngue Mebale, Charleine Manomba Boulingui, Bridy Moutombi Ditombi, Philomène Kouna Ndouongo, Marielle Karine Bouyou Akotet

Abstract readMulticenter StudyEnglish Abstract
In one paragraph

Article in Medecine tropicale et sante internationale, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Michèle Marion Ntsame OwonoService d'infectiologie, Centre hospitalier universitaire de Libreville, Gabon.
Magalie Essomeyo Ngue MebaleService d'infectiologie, Centre hospitalier universitaire de Libreville, Gabon.ORCID 0000-0003-1786-3905
Charleine Manomba BoulinguiService d'infectiologie, Centre hospitalier universitaire de Libreville, Gabon.ORCID 0009-0008-8830-3415
Bridy Moutombi DitombiDépartement des sciences fondamentales et mixtes, Faculté de médecine, Université des sciences de la santé, BP 4000, Gabon Auteur.ORCID 0000-0001-7811-2334
Philomène Kouna NdouongoDépartement de médecine et spécialités médicales, Université des sciences de la santé, BP 4000, Gabon.
Marielle Karine Bouyou AkotetDépartement des sciences fondamentales et mixtes, Faculté de médecine, Université des sciences de la santé, BP 4000, Gabon Auteur.ORCID 0000-0002-7992-4630

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Delays in entry to care are a barrier to immediate initiation of antiretroviral therapy (ART) at diagnosis, as recommended by the World Health Organization. The aim of this study was to determine and compare delays in entry into care and associated factors among people living with HIV (PLHIV) seen at two outpatient treatment centers in Libreville between 2012 and 2020. Materials and methods: Retrospective study based on PLHIV records collected from January 2012 to March 2020 at the two largest outpatient treatment centers (CTA) in Libreville, that of the Centre Hospitalier Universitaire de Libreville (CHUL) and that of Nkembo Hospital. Early entry into care was defined as less than 28 days between diagnosis of HIV infection and first consultation at the CTA. Late entry was defined as more than three months. For analysis, patients were divided into two periods: 2012-2015, when treatment initiation was linked to CD4 count, and 2016-2020, the period when the Results: A total of 979 patients were newly treated in the two CTAs, and the records of 672 individuals could be used. In 48.3% of the cases, HIV infection was diagnosed at a late stage (WHO 3 or 4). The median time to entry into care was 1.2 [IQ: 0-3] months after diagnosis of HIV infection. Between 2016 and 2020, 47% entered care in less than 28 days, compared with 35.7% in 2012-2015 (p < 0.01). The percentage of PLHIV with late entry into care was comparable between the two periods (14.4% vs. 15.9% in 2012-2015; p = 0.62). Factors associated with late entry were WHO stage 3, failure to achieve CD4 count, employment, and pregnancy (p<0.05). Conclusion: In the era of

Indexed as

HIV InfectionsTime-to-TreatmentAdultAmbulatory Care FacilitiesCD4 Lymphocyte CountFemaleGabonHumansMaleMiddle AgedRetrospective StudiesTime FactorsYoung AdultAntiretroviralsGabonHIVLibrevilleSub-Saharan AfricaTime to care

Identifiers

PMID40248583
PMCPMC12001990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.